Taya murna cewa Bigfish Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) an ba shi takardar shaidar CE ta Turai.

A halin yanzu, annobar ta sauya sau da yawa kuma kwayar cutar ta sauya sau da yawa. Dangane da kididdigar da aka fitar a ranar 10 ga Nuwamba, adadin COVID-19 a duniya ya karu da fiye da 540,000, kuma adadin wadanda aka tabbatar sun haura miliyan 250. COVID-19 na daukar nauyin da ba a taba ganin irinsa ba kan lafiya da tattalin arzikin mutane a duniya. shawo kan annobar tun da wuri da dawo da ci gaban tattalin arziki su ne babban fifikon kasashen duniya. Yin la'akari da rigakafin cutar a ƙasashen waje, akwai buƙatun kasuwa mai fa'ida don samfuran antigen na COVID-19.

Kwanan nan, Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) ta Bigfish an ba shi takardar shaidar CE ta Tarayyar Turai. Takaddun shaida na CE, yana ƙara haɓaka layin samfuran kamfanin.

Novel Coronavirus (SARS-CoV-2) Antigen Rapid Test (Colloidal Gold) na Bigfish yana da sauƙin aiki ba tare da kayan aiki ba, kuma yana da sauri don ganowa. Ana samun sakamakon a cikin mintuna 15. Hakanan yana iya gano kamuwa da cuta mai tsanani ko da wuri.

Fuskantar kamuwa da cutar coronavirus, Bigfish zai mai da hankali kan manyan fasahohi tare da tsayayyen salon aiki na gaske. Za mu samar da ingantattun kayayyaki da ayyuka don ba da gudummawar rigakafin cutar ta duniya da sarrafa lafiyar ɗan adam.